These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6746636)

  • 1. Inhibition of dihydropteridine reductase from human liver and rat striatal synaptosomes by apomorphine and its analogs.
    Shen RS; Smith RV; Davis PJ; Abell CW
    J Biol Chem; 1984 Jul; 259(14):8994-9000. PubMed ID: 6746636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rat striatal synaptosomes as a model system for studying the inhibition of dihydropteridine reductase activity.
    Shen RS; Abell CW
    J Enzyme Inhib; 1987; 1(3):223-9. PubMed ID: 3508913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dihydropteridine reductase in rat striatal synaptosomes and from human liver by metabolites of biogenic amines.
    Shen RS
    J Enzyme Inhib; 1985; 1(1):61-6. PubMed ID: 3880425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dihydropteridine reductase by novel 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs.
    Abell CW; Shen RS; Gessner W; Brossi A
    Science; 1984 Apr; 224(4647):405-7. PubMed ID: 6608790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nomifensine and its metabolites on dihydropteridine reductase.
    Shen RS; Sheng WL; Abell CW
    J Pharm Pharmacol; 1984 Jun; 36(6):411-3. PubMed ID: 6146678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine-derived tetrahydroisoquinolines. Novel inhibitors of dihydropteridine reductase.
    Shen R; Smith RV; Davis PJ; Brubaker A; Abell CW
    J Biol Chem; 1982 Jul; 257(13):7294-7. PubMed ID: 7085626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of dihydropteridine reductase by catecholamines and related compounds.
    Shen RS
    Biochim Biophys Acta; 1983 Feb; 743(1):129-35. PubMed ID: 6824696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of dihydropteridine reductase by catechol estrogens.
    Shen RS; Abell CW
    J Neurosci Res; 1983; 10(3):251-9. PubMed ID: 6315964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oxidation of apomorphine and other catechol compounds by horseradish peroxidase: relevance to the measurement of dihydropteridine reductase activity.
    Milstien S; Kaufman S
    Biochim Biophys Acta; 1987 Mar; 923(3):333-8. PubMed ID: 3828376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of dihydropteridine reductase by dopamine.
    Purdy SE; Blair JA; Barford PA
    Biochem J; 1981 Jun; 195(3):769-71. PubMed ID: 7316984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL
    Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and dihydropteridine reductase inhibitory effects of potential metabolites of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Gessner W; Brossi A; Shen R; Abell CW
    J Med Chem; 1985 Mar; 28(3):311-7. PubMed ID: 3871859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibitory effects of tyrosine metabolites on dihydropteridine reductase from human and sheep liver.
    Shen RS
    Biochim Biophys Acta; 1984 Mar; 785(3):181-5. PubMed ID: 6422988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of apomorphine enantiomers and of lisuride on 3,4-dihydroxyphenylalanine production in striatal synaptosomes.
    Bräutigam M; Kittner B; Laschinski G
    Mol Pharmacol; 1985 Dec; 28(6):515-20. PubMed ID: 3935908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain.
    Miller RJ; Kelly PH; Neumeyer JL
    Eur J Pharmacol; 1976 Jan; 35(1):77-83. PubMed ID: 943290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aporphines. 39. Synthesis, dopamine receptor binding, and pharmacological activity of (R)-(-)- and (S)-(+)-2-hydroxyapomorphine.
    Neumeyer JL; Arana GW; Ram VJ; Kula NS; Baldessarini RJ
    J Med Chem; 1982 Aug; 25(8):990-2. PubMed ID: 7120288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
    Gao Y; Zong R; Campbell A; Kula NS; Baldessarini RJ; Neumeyer JL
    J Med Chem; 1988 Jul; 31(7):1392-6. PubMed ID: 3385732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat liver dihydropteridine reductase inhibition.
    Purdy SE; Blair JA
    Biochem Soc Trans; 1980 Oct; 8(5):565-6. PubMed ID: 7450227
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative effects of different inhibitors of phenylalanine hydroxylase and dihydropteridine reductase. In vivo and in vitro study in rats].
    Charpentier C; Domange C; Wolf M; Barthon F; Laggoune B; Lemonnier A
    Arch Fr Pediatr; 1978 Dec; 35(10 Suppl):93-101. PubMed ID: 571268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.